Inactive Instrument
Ark Therapeutics Group plc Stock London S.E.
Stocks
GB0034251727
OTC Markets Traded|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| Market Cap | 5.29M 7.16M 6.17M 5.84M 9.93M 684M 9.98M 69.38M 26.68M 348M 26.89M 26.3M 1.1B | P/E 2024 |
1.51x | P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | -9.39M -12.7M -10.94M -10.36M -17.62M -1.21B -17.71M -123M -47.33M -617M -47.71M -46.66M -1.95B | EV / Sales 2024 |
-0.1x | EV / Sales 2025 | -0.56x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| 01/07/16 | Premier Veterinary : Appointment of Broker | PU |
| 28/06/16 | Premier Veterinary : Further Major Agreement Signed in the US | PU |
| 21/06/16 | Premier Veterinary : Director's Dealings | PU |
| 21/06/16 | Premier Veterinary : Block Listing Application and Directors' Dealings | PU |
| 14/06/16 | Premier Veterinary : Director's Dealings | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Dominic Tonner
CEO | Chief Executive Officer | 69 | 27/02/2015 |
Andrew Paull
DFI | Director of Finance/CFO | 52 | 30/11/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Graham Dick
CHM | Chairman | 75 | 01/03/2018 |
Dominic Tonner
BRD | Director/Board Member | 69 | 27/02/2015 |
Rajan Uppal
BRD | Director/Board Member | 63 | 27/02/2015 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.53M 22.35M 19.26M 18.24M 31.01M 2.14B 31.17M 217M 83.29M 1.09B 83.95M 82.11M 3.43B | 16.85M 22.79M 19.63M 18.59M 31.61M 2.18B 31.77M 221M 84.9M 1.11B 85.57M 83.7M 3.5B |
| Net income | 3.9M 5.28M 4.55M 4.31M 7.33M 505M 7.36M 51.17M 19.68M 257M 19.83M 19.4M 811M | 3.64M 4.93M 4.25M 4.02M 6.84M 471M 6.87M 47.75M 18.36M 240M 18.51M 18.1M 757M |
| Net Debt | -6.94M -9.39M -8.09M -7.66M -13.02M -897M -13.09M -90.94M -34.97M -456M -35.25M -34.47M -1.44B | -14.69M -19.86M -17.11M -16.2M -27.56M -1.9B -27.7M -192M -74.01M -965M -74.6M -72.96M -3.05B |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
